Related Experiment Videos

Overview of B-type natriuretic peptide as a blood test. Roundtable discussion

Peter A McCullough1, Christian Mueller, Clyde W Yancy

  • 1Division of Nutrition and Preventive Medicine, William Beaumont Hospital, Royal Oak, MI 48073-1026, USA. pmc975@yahoo.com

Congestive Heart Failure (Greenwich, Conn.)
|April 6, 2006
PubMed

Insights

This roundtable discusses blood B-type natriuretic peptide testing for cardiovascular disease diagnosis and treatment. Experts explored current and future applications of this vital biomarker.

Area of Science:

  • Cardiology
  • Biomarker Research
  • Diagnostic Testing

Background:

  • Cardiovascular disease remains a leading cause of mortality worldwide.
  • Biomarkers play a crucial role in the diagnosis and management of heart conditions.
  • B-type natriuretic peptide (BNP) testing has emerged as a significant tool in cardiology.

Purpose of the Study:

  • To convene a roundtable discussion on the applications of B-type natriuretic peptide testing.
  • To explore current and future uses of BNP testing in cardiovascular disease.
  • To facilitate expert insights into the role of BNP in diagnosis and treatment.

Main Methods:

  • A roundtable discussion format was employed.
  • Key opinion leaders in cardiology participated.
  • Discussions focused on B-type natriuretic peptide testing applications.

Main Results:

  • The discussion highlighted the established role of BNP testing in diagnosing heart failure.
  • Future applications in risk stratification and guiding therapy were explored.
  • Expert consensus emphasized the value of BNP in managing cardiovascular disease.

Conclusions:

  • B-type natriuretic peptide testing is integral to modern cardiovascular disease management.
  • Continued research and clinical application of BNP testing are essential.
  • The discussion provided valuable insights for clinicians and researchers in the field.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Blood Pressure01:30

Blood Pressure

Blood pressure (BP) is the pressure or force of blood exerted on the artery's walls as it circulates through the body. It is essential for maintaining blood flow throughout the body.
The average BP in an adult is typically around 120/80 mmHg (millimeters of mercury). In this measurement, the numerator (120) indicates the systolic pressure, which is the pressure in the arteries during the contraction of the heart's ventricles as blood is expelled. The denominator (80) represents the diastolic...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...